Indanazoline

RESPIRATORY SYSTEM

Key facts

Indanazoline is a drug catalogued in DrugCentral. Recorded indications include Nasal congestion.

• Indications: Nasal congestion.
• ATC code: R01AA15 (Sympathomimetics, plain).
• Molecular formula: C12H15N3; molecular weight 201.27 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Nasal congestion

ATC classification

ATC code	Therapeutic hierarchy
R01AA15	RESPIRATORY SYSTEM › NASAL PREPARATIONS › DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE › Sympathomimetics, plain

Chemical structure

• Molecular formula: C₁₂H₁₅N₃
• Molecular weight: 201.27 g/mol
• CAS number: 40507-78-6
• InChIKey: KUCWWEPJRBANHL-UHFFFAOYSA-N
• PubChem CID: 65979

C1CC2=C(C1)C(NC1=NCCN1)=CC=C2

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Indanazoline used for?

DrugCentral lists the following indications for Indanazoline: Nasal congestion.

What is the chemical formula of Indanazoline?

Indanazoline has the molecular formula C12H15N3 and a molecular weight of 201.27 g/mol.

Sources

• DrugCentral drug card 3298 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL2104824 — compound record and bioactivity
• PubChem CID 65979 — chemical identifiers
• DrugBank DB13827 — drug record
• FDA UNII L0U38EHD86 — substance identity

How this page is built: methodology · editorial policy & corrections.